Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Restart Life Sciences Corp. (TSE:HEAL)
:HEAL
HEAL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.21
Previous CloseN/A
Volume800.00
Average Volume (3M)28.63K
Market Cap
C$1.72M
Enterprise ValueC$575.58K
Total Cash (Recent Filing)654.34K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)122.2
Beta1.98
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding18,126,950
10 Day Avg. Volume15,203
30 Day Avg. Volume28,633
Standard Deviation0.40
R-Squared0.00882
Alpha-0.00102
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-96.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
HEAL FAQ
What was Restart Life Sciences Corp.’s price range in the past 12 months?
Restart Life Sciences Corp. lowest stock price was C$0.03 and its highest was C$0.21 in the past 12 months.
What is Restart Life Sciences Corp.’s market cap?
Restart Life Sciences Corp.’s market cap is C$1.72M.
When is Restart Life Sciences Corp.’s upcoming earnings report date?
Restart Life Sciences Corp.’s upcoming earnings report date is Apr 24, 2025 which is in 61 days.
How were Restart Life Sciences Corp.’s earnings last quarter?
Restart Life Sciences Corp. released its earnings results on Nov 29, 2024. The company reported C$0.031 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.031.
Is Restart Life Sciences Corp. overvalued?
According to Wall Street analysts Restart Life Sciences Corp.’s price is currently Overvalued.
Does Restart Life Sciences Corp. pay dividends?
Restart Life Sciences Corp. does not currently pay dividends.
What is Restart Life Sciences Corp.’s EPS estimate?
Restart Life Sciences Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Restart Life Sciences Corp. have?
Restart Life Sciences Corp. has 18,126,950 shares outstanding.
What happened to Restart Life Sciences Corp.’s price movement after its last earnings report?
Restart Life Sciences Corp. reported an EPS of C$0.031 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -14.286%.
Which hedge fund is a major shareholder of Restart Life Sciences Corp.?
Currently, no hedge funds are holding shares in TSE:HEAL
---
Company Description
Restart Life Sciences Corp.
Liberty Leaf Holdings Ltd. engages in building and supporting a diversified portfolio of cannabis-sector businesses. It offers cultivation, processing, value-added cannabidiol & pet products, and supply chain products. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
---
Technical Analysis
---